|
gptkbp:instance_of
|
gptkb:pharmaceuticals
gptkb:Nobel_Peace_Prize
|
|
gptkbp:affiliation
|
gptkb:William_Harvey_Research_Institute
|
|
gptkbp:alma_mater
|
gptkb:University_of_London
|
|
gptkbp:awards
|
gptkb:Nobel_Prize_in_Physiology_or_Medicine
|
|
gptkbp:birth_place
|
gptkb:Trowbridge,_Wiltshire,_England
|
|
gptkbp:born
|
March 29, 1927
|
|
gptkbp:children
|
three
|
|
gptkbp:contribution
|
understanding of blood pressure regulation
role of endothelium in vascular function
|
|
gptkbp:death_place
|
gptkb:London,_England
|
|
gptkbp:died
|
November 19, 2018
|
|
gptkbp:field
|
Pharmacology
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sir John Vane
|
|
gptkbp:influenced
|
pharmaceutical development
cardiovascular medicine
|
|
gptkbp:known_for
|
discovering the role of nitric oxide as a signaling molecule
Vane's hypothesis on prostacyclin
research on angiotensin II
|
|
gptkbp:nationality
|
gptkb:British
|
|
gptkbp:published_work
|
' The Role of Nitric Oxide in the Cardiovascular System'
|
|
gptkbp:research_focus
|
vascular biology
|
|
gptkbp:spouse
|
gptkb:Lady_Vane
|
|
gptkbp:bfsParent
|
gptkb:Medical_School
|
|
gptkbp:bfsLayer
|
4
|